medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2025; 23 (2)

Pemphigus vulgaris and coexistence with herpes virus: a case report

Figueroa HMF, Polanco LAS, Parra JLS, Berumen-Glinz C, Vega MME
Full text How to cite this article

Language: Spanish
References: 12
Page: 104-108
PDF size: 263.99 Kb.


Key words:

pemphigus vulgaris, herpes virus, acantholysis, pathogenesis.

ABSTRACT

Pemphigus vulgaris (PV) is an autoimmune disease characterized by involvement of the mucous membranes and skin with suprabasal acantholytic vesicles, caused by autoantibodies targeting keratinocyte junctions. It has been associated with infection by herpes simplex virus (HSV), through molecular mimicry or activating autoimmune potential. This association has been described as a complication of pv immunosuppressive therapy, or as a trigger for pemphigus with a role in its etiopathogenesis; or alternatively, without evidence of viral infection.
We report a 16-year-old male patient diagnosed with pv who initiated immunosuppressive treatment without improvement, was clinically reassessed and HSV was identified. Treatment with acyclovir was initiated and, in conjunction with the baseline treatment, resolution of the lesions was achieved.


REFERENCES

  1. Konda D, Chandrashekar L, Dhodapkar R, Ganesh RN y ThappaDM, Clinical markers of herpes simplex virus infection inpatients with pemphigus vulgaris, J Am Acad Dermatol 2023;88(3):587-92.

  2. Mihai S y Sitaru C, Immunopathology and molecular diagnosisof autoimmune bullous diseases, J Cell Mol Med 2007;11(3):462-81.

  3. Hertl M, Eming R, Veldman C, T cell control in autoimmune bullousskin disorders, J Clin Invest 2006; 116(5):1159-66.

  4. Nikkels AF, Delvenne P, Herfs M y Pierard GE, Occult herpessimplex virus colonization of bullous dermatitides, Am J ClinDermatol 2008; 9(3):163-8.

  5. Marzano AV, Tourlaki A, Merlo V, Spinelli D, Venegoni L y CrostiC, Herpes simplex virus infection and pemphigus, Int J ImmunopatholPharmacol 2009; 22(3):781-6.

  6. Kalra A, Ratho RK, Kaur I y Kumar B, Role of herpes simplex andcytomegalo viruses in recalcitrant oral lesions of pemphigusvulgaris, Int J Dermatol 2005; 44(3):259-60.

  7. Kneisel A y Hertl M, Autoimmune bullous skin diseases. Part 1:Clinical manifestations, J Dtsch Dermatol Ges 2011; 9(10):844-56.

  8. Uriarte Ruiz K y Vega Memije ME, Casuística de pénfigo en elHospital General Dr. Manuel Gea González, 1980-2021, DermatologíaCosmética, Médica y Quirúrgica 2022; 20(1):88-90.

  9. Murrell DF, Dick S, Ahmed AR et al., Consensus statement ondefinitions of disease, end points, and therapeutic response forpemphigus, J Am Acad Dermatol 2008; 58(6):1043-6.

  10. Ruocco E, Ruocco V, Lo Schiavo A et al., Viruses and pemphigus:an intriguing never-ending story, Dermatology 2014;229(4):310-5.

  11. Vega Memije ME, García Vázquez FJ, Cuevas González JC, RodríguezLobato E y Aguilar-Urbano MA, Is there a causal relationshipbetween hsv-1 and pemphigus vulgaris?, Springerplus2015; 23(4):811.

  12. Yanduri S, Gokuldas A, Kumar VB et al., Herpes simplex virus: aseed or sequelae to pemphigus?, J Dent Res 2019; 10(3):154-7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2025;23